Eppendorf Continues Successful Development
News May 03, 2016
The Eppendorf Group concluded fiscal year 2015 with Group sales of €629.1 million (prior year: €531.1 million) and growth in sales of 18.5% (7.1% when adjusted for currency effects). Income from operations (EBIT) climbed 24.7% to €119.3 million (prior year: €95.7 million).
Eppendorf’s growth last year encompassed all its product groups, and the company profited from the positive development of both traditional and new markets. Investments were made in the subsidiaries, including new facilities in Brazil and India, and in the expansion of Eppendorf’s sales structures. 2015 also saw an increase in research and development expenditures to €31.9 million (prior year: €29.4 million).
Thomas Bachmann, Chief Executive Officer of Eppendorf AG, was satisfied with the company’s result: “In 2015 we grew organically at a level well above the industry average of 4 to 5%, which is itself healthy. Significant success factors in our development are our innovative momentum, the high quality of our products, and a staff committed to doing the best for our customers every day. Our investments in sales and in the expansion of our services are also paying off.”
In 2016, the company intends to focus on device and data networking as well as product and application developments. Additional investments in the expansion of the country organizations and the development and production facilities are also planned.
"Genetic Jenga" Helps Understand How Our Genes Control Our CellsNews
To fully understand how our cells work, we can't focus on just one gene, but must instead look at combinations of genes. Researchers have published a study which knocked out multiple genes, like removing bricks from a Jenga tower, to better understand how they work together.READ MORE
Southeast Asian Nomads Have Evolved to Hunt Fish UnderwaterNews
The human spleen can release oxygenated blood cells to allow more time underwater without breathing. A new study has identified that the "Sea Nomad" Bajau people of Indonesia have evolved larger spleens that would allow them to remain underwater for longer.READ MORE
Gene Therapy Could End Transfusions for Blood Disorder PatientsNews
Beta-thalassemia patients need a regular dose of red blood cells transfused into their body. A new gene therapy that edits faulty genes in the patients' cells could end this monthly ritual.READ MORE